NDC 79378-110
Livmarli
Maralixibat Chloride
Livmarli is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Mirum Pharmaceuticals Inc.. The primary component is Maralixibat Chloride.
| Product ID | 79378-110_6a9777ef-47c8-471b-b93f-d097364f0575 |
| NDC | 79378-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Livmarli |
| Generic Name | Maralixibat Chloride |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-09-29 |
| Marketing Category | NDA / |
| Application Number | NDA214662 |
| Labeler Name | Mirum Pharmaceuticals Inc. |
| Substance Name | MARALIXIBAT CHLORIDE |
| Active Ingredient Strength | 10 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 79378-110-01
1 BOTTLE in 1 CARTON (79378-110-01) > 30 mL in 1 BOTTLE
| Marketing Start Date | 2021-09-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
Trademark Results [Livmarli]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LIVMARLI 88857240 not registered Live/Pending |
Mirum Pharmaceuticals, Inc. 2020-04-02 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.